Wilmen A, Göke B, Göke R
Clinical Research Group for Gastrointestinal Endocrinology, Philipps-University of Marburg, Germany.
FEBS Lett. 1996 Nov 25;398(1):43-7. doi: 10.1016/s0014-5793(96)01214-8.
The glucagon-like peptide 1 (7-37)/(7-36) amide (GLP-1) receptor belongs to a new subclass of seven transmembrane domain, G-protein coupled receptors comprising several receptors for peptide hormones. The receptors of this family share many common motifs including a relatively large N-terminal extracellular domain. The GLP-1 receptor is presently attracting much attention, since it is the target protein of the antidiabetic gut hormone GLP-1. To establish the functional significance of the N-terminal part of the GLP-1 receptor for ligand binding, the extracellular domain was isolated and purified. Utilizing CHL cells expressing the cloned GLP-1 receptor, we demonstrate that the isolated, solubilized N-terminal part of the receptor protein competes for GLP-1 binding with the intact wild-type receptor. Moreover, in cross-linking experiments radiolabeled GLP-1 was covalently attached to the isolated N-terminus, thereby demonstrating direct physical interaction of both components. By Western blot analysis two specific bands were detectable, representing the N-terminal receptor protein in the presence or absence of bound ligand. These data underline the significance of the N-terminal domain of the GLP-1 receptor for ligand binding.
胰高血糖素样肽1(7-37)/(7-36)酰胺(GLP-1)受体属于七跨膜结构域G蛋白偶联受体的一个新亚类,该亚类包括几种肽激素受体。这个家族的受体有许多共同基序,包括一个相对较大的N端细胞外结构域。GLP-1受体目前备受关注,因为它是抗糖尿病肠激素GLP-1的靶蛋白。为了确定GLP-1受体N端部分在配体结合中的功能意义,分离并纯化了细胞外结构域。利用表达克隆的GLP-1受体的CHL细胞,我们证明分离的、可溶解的受体蛋白N端部分与完整的野生型受体竞争GLP-1结合。此外,在交联实验中,放射性标记的GLP-1与分离的N端共价连接,从而证明了两者之间的直接物理相互作用。通过蛋白质免疫印迹分析可检测到两条特异性条带,分别代表存在或不存在结合配体时的N端受体蛋白。这些数据强调了GLP-1受体N端结构域在配体结合中的重要性。